Key result
Myeloproliferative neoplasms linked to ~17% lower in-hospital mortality or cardiac arrest after AMI, despite higher bleeding.
Observational (n=1,644,304)
Yes
Answers are grounded in this paper and cite their sources.
Myeloproliferative neoplasms (MPNs) are hematopoietic stem cell neoplasms with a high risk of thrombosis, including acute myocardial infarction (AMI). However, outcomes after AMI have not been thoroughly characterized. The purpose of this study was to characterize outcomes after AMI in patients with MPNs compared with patients without MPNs. Patients with a primary admission of AMI from January 2006 to December 2018 were identified using the National Inpatient Sample. Outcomes of interest included in-hospital death or cardiac arrest (CA) and major bleeding. Propensity score weighting was used to compare outcomes between MPN and non-MPN groups. A total of 1,644,304 unweighted admissions for AMI were included; of these admissions, 5,374 (0.3%) were patients with MPNs. After propensity score weighting, patients with MPNs had a lower risk of in-hospital death or CA (OR: 0.83; 95% CI: 0.82-0.84) but a higher risk of major bleeding (OR: 1.29; 95% CI: 1.28-1.30) compared with non-MPN patients. There was a decreasing temporal rate of in-hospital death or CA and bleeding in patients without MPNs (Ptrend < 0.001 for both). However, there was an increasing temporal rate of in-hospital death or CA (Ptrend < 0.001) and a stable rate of major bleeding (Ptrend = 0.48) in patients with MPNs. Among patients hospitalized with AMI, patients with MPNs have a lower risk of in-hospital death or CA compared with patients without MPNs, although they have a higher risk of bleeding. More investigation is needed in order to improve post-AMI bleeding outcomes in patients with MPN.
No takes yet. Share an insight, caveat, or question.
Leiva et al. (2023) conducted an observational in Acute myocardial infarction with or without myeloproliferative neoplasms (n=1,644,304). Myeloproliferative neoplasms (MPNs) vs. Patients without myeloproliferative neoplasms (non-MPN) was evaluated on In-hospital death or cardiac arrest (OR 0.83, 95% CI 0.82-0.84). Myeloproliferative neoplasms were associated with lower in-hospital death or cardiac arrest but higher major bleeding after AMI.
Synapse has enriched 10 related papers. Consider them for comparative context: